Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study
Mingli Luo, Jiahao Cai, Shulu Luo, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 46
Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats
Li Cheng, Xulong Chen, Jingchun Yao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314029-e0314029
Open Access | Times Cited: 2
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 44
Dietary Polysaccharides as Modulators of the Gut Microbiota Ecosystem: An Update on Their Impact on Health
Ana I. Álvarez‐Mercado, Julio Plaza‐Díaz
Nutrients (2022) Vol. 14, Iss. 19, pp. 4116-4116
Open Access | Times Cited: 39
Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes—A Systematic Review
Luminița Voroneanu, Alexandru Burlacu, Crischentian Brinza, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1948-1948
Open Access | Times Cited: 30
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Synbiotics, prebiotics and probiotics for people with chronic kidney disease
Tess E Cooper, Rabia Khalid, Samuel Chan, et al.
Cochrane library (2023) Vol. 2023, Iss. 10
Closed Access | Times Cited: 26
The Kidney–Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression
Sandra Cabała, M. Ożgo, Agnieszka Herosimczyk
Metabolites (2024) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 14
Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor
Hongyan Xie, Ninghao Yang, Chen Yu, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management
Tao Han Lee, Jia‐Jin Chen, Chao‐Yi Wu, et al.
Biomedical Journal (2023) Vol. 47, Iss. 2, pp. 100638-100638
Open Access | Times Cited: 18
Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis
Takuya Wakamatsu, Suguru Yamamoto, Shiori Yoshida, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 254-254
Open Access | Times Cited: 6
Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement
You-Tae Kim, David A. Mills
Food Science and Biotechnology (2024) Vol. 33, Iss. 9, pp. 2065-2080
Closed Access | Times Cited: 6
Gut Microbiota Interventions to Retain Residual Kidney Function
Denise Mafra, Julie Ann Kemp, Natália Alvarenga Borges, et al.
Toxins (2023) Vol. 15, Iss. 8, pp. 499-499
Open Access | Times Cited: 14
Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study
Inès Obolo Nwaga, Victorine Nzana, Rhoda Nsen Bughe, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Exploring the Potential Use of Probiotics, Prebiotics, Synbiotics, and Postbiotics as Adjuvants for Modulating the Vaginal Microbiome: a Bibliometric Review
Douglas Xavier-Santos, Raquel Bedani, Isabel Vieira, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Effects of Dietary Fiber Supplementation on Modulating Uremic Toxins and Inflammation in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Wannasit Wathanavasin, Wisit Cheungpasitporn, Charat Thongprayoon, et al.
Toxins (2025) Vol. 17, Iss. 2, pp. 57-57
Open Access
The role of the intestinal microbiome in cognitive decline in patients with kidney disease
Carsten A. Wagner, Isabelle Frey‐Wagner, Alberto Ortíz, et al.
Nephrology Dialysis Transplantation (2025) Vol. 40, Iss. Supplement_2, pp. ii4-ii17
Open Access
Impact of Gut Microbiome Modulation on Uremic Toxin Reduction in Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
Renata Cedillo-Flores, Miguel Ángel Cuevas‐Budhart, Iván Cavero‐Redondo, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1247-1247
Open Access
Health benefits of medicinal plant natural products via microbiota-mediated different gut axes
Xiang Li, Yufan Liu, Ning Liu, et al.
Pharmacological Research (2025), pp. 107730-107730
Open Access
Structural characteristics and biological activities of polysaccharides from barley: a review
Haoyingye Yao, Junyi Yin, Shaoping Nie
Food & Function (2024) Vol. 15, Iss. 7, pp. 3246-3258
Closed Access | Times Cited: 4
Recent advances of gut microbiota in chronic kidney disease patients
Ying‐Yong Zhao
Exploration of Medicine (2022), pp. 260-274
Open Access | Times Cited: 17
The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease
Weerapat Anegkamol, Panumas Kamkang, Sittiphong Hunthai, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3363-3363
Open Access | Times Cited: 9
The Gut–Kidney Axis in Chronic Kidney Diseases
Kenji Tsuji, Naoyuki Uchida, Hiroyuki Nakanoh, et al.
Diagnostics (2024) Vol. 15, Iss. 1, pp. 21-21
Open Access | Times Cited: 3
Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation
Zheng Lin, Mingjing Luo, Haokui Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 8
A Scoping Review Evaluating the Current State of Gut Microbiota Research in Africa
Sara Mosima Pheeha, Jacques L. Tamuzi, Bettina Chale-Matsau, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2118-2118
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top